Does prolonged biliary obstructive jaundice sensitize the liver to endotoxemia?

Shock

Volumn 31, Issue 4, 2009, Pages 397-403

  Iida, Ayako ^a   Yoshidome, Hiroyuki ^a   Shida, Takashi ^a   Kimura, Fumio ^a   Shimizu, Hiroaki ^a   Ohtsuka, Masayuki ^a   Morita, Yasuhiro ^a   Takeuchi, Dan ^a   Miyazaki, Masaru ^a  

^a CHIBA UNIVERSITY   (Japan)

Author keywords

Apoptosis; Death signal; Fas ligand; Liver failure; Transcription factor

Indexed keywords

ADENOSINE TRIPHOSPHATE; ALANINE AMINOTRANSFERASE; CASPASE 3; CASPASE 8; CASPASE 9; FAS LIGAND; LIPOPOLYSACCHARIDE; POLY(ADENOSINE DIPHOSPHATE RIBOSE); PROTEIN P85;

ALANINE AMINOTRANSFERASE BLOOD LEVEL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; BILE DUCT LIGATION; BILE DUCT OBSTRUCTION; C57BL 6 MOUSE; CONTROLLED STUDY; ENDOTOXEMIA; IMMUNOHISTOCHEMISTRY; LIVER; LIVER CELL; LIVER NECROSIS; MALE; MOUSE; NONHUMAN; OBSTRUCTIVE JAUNDICE; PROTEIN EXPRESSION; SHAM PROCEDURE; SURVIVAL; WESTERN BLOTTING;

ADENOSINE TRIPHOSPHATE; ALANINE TRANSAMINASE; ANIMALS; APOPTOSIS; BILIRUBIN; DISEASE MODELS, ANIMAL; ENDOTOXEMIA; FAS LIGAND PROTEIN; HUMANS; JAUNDICE, OBSTRUCTIVE; LIPOPOLYSACCHARIDES; LIVER; LIVER DISEASES; MALE; MICE; MICE, INBRED C57BL;

EID: 64849104272     PISSN: 10732322     EISSN: None     Source Type: Journal    
DOI: 10.1097/SHK.0b013e31818349ea     Document Type: Article

References (36)

1. Pain JA, Cahill CJ, Bailey ME: Perioperative complications in obstructive jaundice: therapeutic considerations. Br J Surg 72:942-945, 1985.
2. Su CH, Tsay SH, Wu CC, Shyr YM, King KL, Lee CH, Lui WY, Liu TJ, P'eng FK: Factors influencing postoperative morbidity, mortality, and survival after resection for hilar cholangiocarcinoma. Ann Surg 223:384-394, 1996.
3. Dixon JM, Armstrong CP, Duffy SW, Davies GC: Factors affecting morbidity and mortality after surgery for obstructive jaundice: a review of 373 patients. Gut 24:845-852, 1983.
4. Lipsett PA, Pitt HA: Acute cholangitis. Surg Clin North Am 70:1297-1231, 1990.
5. Nagino M, Kamiya J, Uesaka K, Sano T, Yamamoto H, Hayakawa N, Kanai M, Nimura Y: Complications of hepatectomy for hilar cholangiocarcinoma. World J Surg 25:1277-1283, 2001.
6. Belghiti J, Hiramatsu K, Benoist S, Massault P, Sauvanet A, Farges O: Seven hundred forty-seven hepatectomies in the 1990s: an update to evaluate the actual risk of liver resection. J Am Coll Surg 191:38-46, 2000.
7. Faubion WA, Guicciardi ME, Miyoshi H, Bronk SF, Roberts PJ, Svingen PA, Kaufmann SH, Gores GJ: Toxic bile salts induce hepatocyte apoptosis via direct activation of Fas. J Clin Invest 103:137-145, 1999.
8. Miyoshi H, Rust C, Roberts PJ, Burgart LJ, Gores GJ: Hepatocyte apoptosis after bile duct ligation in the mouse involves Fas. Gastroenterology 117:669-677,1999.
9. Peter ME, Krammer PH: Mechanisms of CD95(APO-l/Fas)-mediated apoptosis. Curr Opin Immunol 10:545-551, 1998.
10. Yerushalmi B, Dahl R, Devereaux MW, Gumpricht E, Sokol RJ: Bile acid-induced rat hepatocyte apoptosis is inhibited by antioxidants and blockers of the mitochondrial permeability transition. Hepatology 33:616-626, 2001.
11. Wang X: The expanding role of mitochondria in apoptosis. Genes Dev 15:2922-2933, 2001.
12. Jaeschke H, Lemasters JJ: Apoptosis versus oncotic necrosis in hepatic ischemia/reperfusion injury. Gastroenterology 125:1246-1257, 2003.
13. Takeuchi D, Yoshidome H, Kato A, Ito H, Kimura F, Shimizu H, Ohtsuka M, Morita Y, Miyazaki M: Interleukin 18 causes hepatic ischemia/reperfusion injury by suppressing anti-inflammatory cytokine expression in mice. Hepatology 39:699-710, 2004.
14. Schwabe RF, Brenner DA: Mechanisms of liver injury. I. TNF-alpha-induced liver injury: role of IKK, JNK, and ROS pathways. Am J Physiol Gastrointest Liver Physiol 290:G583-G589, 2006.
15. Nimura Y, Kamiya J, Kondo S, Nagino M, Uesaka K, Oda K, Sano T, Yamamoto H, Hayama N: Aggressive perioperative management and extended surgery for hilar cholangiocarcinoma: Nagoya experience. J Hepatobiliary Pancreat Surg 7:155-162, 2000.
16. Kawasaki S, Imamura H, Kobayashi A, Noike T, Miwa S, Miyagawa S: Results of surgical resection for patients with hilar bile duct cancer: application of extended hepatectomy after biliary drainage and hemihepatic portal vein embolization. Ann Surg 238:84-92, 2003.
17. Cherqui D, Benoist S, Malassagne B, Humeres R, Rodriguez V, Fagniez PL: Major liver resection for carcinoma in jaundiced patients without preoperative biliary drainage. Arch Surg 135:302-308, 2000.
18. Rodrigues CM, Steer CJ: Mitochondrial membrane perturbations in cholestasis. J Hepatol 32:135-141, 2000.
19. Patel T, Gores GJ: Apoptosis and hepatobiliary disease. Hepatology 21: 1725-1741, 1995.
20. Canbay A, Feldstein AE, Higuchi H, Wemeburg N, Grambihler A, Bronk SF, Gores GJ: Kupffer cell engulfment of apoptotic bodies stimulates death ligand and cytokine expression. Hepatology 38:1188-1198, 2003.
21. Greve JW, Gouma DJ, Soeters PB, Buurman WA: Suppression of cellular immunity in obstructive jaundice is caused by endotoxins: a study with germfree rats. Gastroenterology 98:478-485, 1990.
22. Duriez PJ, Shah GM: Cleavage of poly (ADP-ribose) polymerase: a sensitive parameter to study cell death. Biochem Cell Biol 75:337-349, 1997.
23. Simbulan-Rosenthal CM, Rosenthal DS, Iyer S, Boulares AH, Smulson ME: Transient poly(ADP-ribosyl)ation of nuclear proteins and role of poly(ADP- ribose) polymerase in the early stages of apoptosis. J Biol Chem 273: 13703-13712, 1998.
24. Schmucker DL, Ohta M, Kanai S, Sato Y, Kitani K: Hepatic injury induced by bile salts: correlation between biochemical and morphological events. Hepatology 12:1216-1221, 1990.
25. Power C, Fanning N, Redmond HP: Cellular apoptosis and organ injury in sepsis: a review. Shock 18:197-211, 2002.
26. Yin XM: Bid, a critical mediator for apoptosis induced by the activation of fas/TNF-R1 death receptors in hepatocytes. J Mol Med 78:203-211, 2000.
27. Leist M, Single B, Castoldi AF, Kuhnle S, Nicotera P: Intracellular adenosine triphosphate (ATP) concentration: a switch in the decision between apoptosis and necrosis. J Exp Med 185:1481-1486, 1997.
28. Malhi H, Gores GJ, Lemasters JJ: Apoptosis and necrosis in the liver: a tale of two deaths? Hepatology 43:S31-S44, 2006.
29. Griffith TS, Brunner T, Fletcher SM, Green DR, Ferguson TA: Fas ligandinduced apoptosis as a mechanism of immune privilege. Science 270: 1189-1192, 1995.
30. Chen JJ, Sun Y, Nabel GJ: Regulation of the proinflammatory effects of fas ligand (CD95L). Science 282:1714-1717, 1998.
31. Morita Y, Yoshidome H, Kimura F, Shimizu H, Ohtsuka M, Takeuchi D, Mitsuhashi N, Iida A, Miyazaki M: Excessive inflammation but decreased immunological response renders liver susceptible to infection in bile duct ligated mice. J Surg Res 146:262-270, 2008.
32. Faouzi S, Burckhardt BE, Hanson JC, Campe CB́, Schrum LW, Rippe RA, Maher JJ: Anti-Fas induces hepatic chemokines and promotes inflammation by an NF-kappa B-independent, caspase-3-dependent pathway. J Biol Chem 276:49077-49082, 2001.
33. Kennedy JA, Clements WD, Kirk SJ, McCaigue MD, Campbell GR, Erwin PJ, Halliday MI, Rowlands BJ: Characterization of the Kupffer cell response to exogenous endotoxin in a rodent model of obstructive jaundice. Br J Surg 86: 628-633, 1999.
34. Minutoli L, Altavilla D, Bitto A, Polito F, Bellocco E, Lagana G, Giuliani D, Fiumara T, Magazu S, Ruggeri P, et al.: The disaccharide trehalose inhibits proinflammatory phenotype activation in macrophages and prevents mortality in experimental septic shock. Shock 27:91-96, 2007.
35. Nagino M, Nimura Y, Hayakawa N, Kamiya J, Kondo S, Sasaki R, Hamajima N: Logistic regression and discriminant analysis of hepatic failure after liver resection for carcinoma of the biliary tract World J Surg 17:250-255, 1993.
36. van der Gaag NA, de Castro SM, Rauws EA, Bruno MJ, van Eijck CH, Kuipers EJ, Gerritsen JJ, Rutten JP, Greve JW, Hesselink EJ, et al.: Preoperative biliary drainage for periampullary tumors causing obstructivejaundice; DRainage vs. (direct) OPeration (DROP-trial). BMC Surg 7:3, 2007.